Drug recall

Recovered Plasma

FDA recall event 36571 · Class II · Oklahoma Blood Institute - Sylvan N Goldman Center

Key facts

Event ID 36571
Recall numbers B-0516-7, B-0517-7
Recalling firm Oklahoma Blood Institute - Sylvan N Goldman Center
Product type Biologics
Products Recovered Plasma, Red Blood Cells, Leukocytes Reduced
Classification Class II
Status Terminated
Voluntary or mandated Firm Initiated
Reason for recall Blood products, collected from an ineligible donor due to use of the medication Methotrexate, were distributed.
Initiation date Mar 28, 2005
Termination date Jan 9, 2007
City Oklahoma City
Country United States
FEI number 1626009

At a glance

  • 1–9 Products in this recall
  • 10–99 FDA inspections of this firm (FEI)

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA drug and product recalls

FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.

Source: U.S. Food and Drug Administration (FDA), Enforcement Reports

Browse all FDA drug and product recalls